Aster DM Healthcare shareholding pattern

ASTERDM

755.5

8.90 (1.19%)
Last updated on 15 May, 2026 | 11:14 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aster DM Healthcare Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

40.39%

Mutual Fund

26.45%

Insurance

0.67%

Foreign Institutional Investors

17.18%

Domestic Institutional Investors

0.45%

Retail

14.85%

Others

0.01%

Total Promoters
MAR '26
40.39%

Summary

Aster DM Healthcare share holding pattern reports the following shareholding: Aster DM Healthcare Total Promoters is at 40.39%, Mutual Fund at 26.45%, Insurance at 0.67%, Foreign Institutional Investors at 17.18%, Domestic Institutional Investors at 0.45%, and Retail at 14.85%. This breakdown provides a quick snapshot of ownership distribution for Aster DM Healthcare share holding pattern in 2026-27.

Aster DM Healthcare FAQs

As of 05-2026, the promoter shareholding in Aster DM Healthcare stands at 40.39% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Aster DM Healthcare is 17.18% and 0.45% respectively.

The retail shareholding of the Aster DM Healthcare is 14.85%.

Changes in shareholding patterns of Aster DM Healthcare can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Aster DM Healthcare are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost